Acquiring Company
Valerio Therapeutics
Acquired Company
eTheRNA
North Brabant
AntwerpenBiotechnologyHealth CareTherapeuticsManufacturingBiotechnologyTherapeuticsDescription
On October 12, 2026, Valerio Therapeutics announced the completion of its acquisition of 100% of Etherna Immunotherapies NV. This two-stage transaction was finalized after the settlement of shares issued in exchange for Etherna securities. Valerio aims to leverage Etherna's expertise in RNA therapy to enhance targeted treatment capabilities. The acquisition marks a significant milestone in Valerio's strategy to accelerate RNA therapeutics development.
Quick answer
Valerio Therapeutics is acquiring eTheRNA, announced October 12, 2026. Valerio Therapeutics is based in North Brabant, Netherlands.
- How much did Valerio Therapeutics pay for eTheRNA?
- The deal value was not disclosed.
- What does Valerio Therapeutics do?
- Valerio Therapeutics is a biotechnology company focused on RNA therapeutics.
- Where are Valerio Therapeutics and eTheRNA based?
- Valerio Therapeutics is based in North Brabant, Netherlands. eTheRNA is based in Antwerpen, Antwerp, Belgium.
Source: Fundz verified event record.
Other recent acquisitions in Therapeutics and Therapeutics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Lineage acquires NeuroAirmid Therapeutics (November 12, 2026)
- Nuformix proposes merger with Biovara (November 11, 2026)
- Abeona Therapeutics to Acquire APT-1011 Assets from Ellodi Pharmaceuticals (November 9, 2026)
- Acrivon Therapeutics Acquires Aqilion’s Drug Development Programs (November 6, 2026)
- BioAdaptives, Inc. to acquire Xycota Biosciences LLC to Expand Biotechnology Portfolio (November 4, 2026)
- Western Microsurgical acquires Q Surgical and Proficient Surgical (October 27, 2026)
Who to call at Valerio Therapeutics, and when
When Valerio Therapeutics changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Valerio Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Valerio Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Valerio Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Valerio Therapeutics makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired eTheRNA?
eTheRNA was acquired by Valerio Therapeutics, based in North Brabant. The deal was reported on October 12, 2026. Valerio Therapeutics is a biotechnology company focused on RNA therapeutics. The company specializes in developing innovative therapies utilizing nucleic acid chemistry. Valerio Therapeutics is privately held and operates in Biotechnology.
When did Valerio Therapeutics acquire eTheRNA?
Valerio Therapeutics's acquisition of eTheRNA was reported on October 12, 2026. On October 12, 2026, Valerio Therapeutics announced the completion of its acquisition of 100% of Etherna Immunotherapies NV. This two-stage transaction was finalized after the settlement of shares issued in exchange for Etherna securities. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does eTheRNA do?
It is privately held, operating in Manufacturing, and is based in Antwerpen.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.